Medelys Laboratoires International Inc. Lun - Ven : 9.00 - 17.00 | Sam/Dim : FERMÉ
(514) 631-1212 COMMANDER CONTACTEZ-NOUS

Références – Qu’est-ce que Krilex?

Références – Qu’est-ce que Krilex?

1. Blanchet C, Lucas M, Julien P, Morin R, Gingras S, Dewailly E. Fatty acid composition of wild and farmed Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss). Lipids 40:529-31, 2005.

2. Dewailly E, Ayotte P, Lucas M, Blanchet C. Risk and benefits from consuming salmon and trout: a Canadian perspective. Food Chem Toxicol 45:1343-1348, 2007.

3. Lands, W. Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease. Ann New York Acad Scis (Blackwell) 1055: 179–192, 2005.

4. Hibbeln JR, Nieminen LRG, Blasbalg TL, Riggs JA and Lands W. Healthy intakes of n−3 and n−6 fatty acids: estimations considering worldwide diversity. Am J Clinl Nutr 83: 1483S–1493S., 2006.

5. Okuyama H, Ichikawa Y, Sun Y, Hamazaki T and Lands W. (2007). ω3 fatty acids effectively prevent coronary heart disease and other late-onset diseases: the excessive linoleic acid syndrome. World Rev Nutr Diet 96: 83–103, 2007.
6. Daley CA, Abbott AC, Doyle P, Nader G and Larson S. A review of fatty acid profile and antioxidant content in grass-fed and grain-fed beef. Nutr J 9:10-22, 2004. http://www.csuchico.edu/agr/grassfedbeef/health-benefits/index.html.

7. Simopoulos, AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy 56: 365–379, 2002.

8. British Nutrition Foundation. 1992. Unsaturated fatty acids: nutritional and physiological significance. The Report of the British Nutrition Foundations’Task Force. London:British Nutrition Foundation.

9. Lands WE. 1992. Biochemistry and physiology of n-3 fatty acids. The FASEB J 6: 2530-2536. (Review).

10. Roche HM. 1999. Unsaturated fatty acids. Proc Nutr Soc 58: 397-401.

11. Galli C, Simopolous AP, editors. Dietary ω3 and ω6 fatty acids. Biological Effects and Nutritional Essentiality. New York (NY): Plenum Press; 1989.

12. 12, Horrocks LA and Yeo YK. 1999. Health benefits of docosahexaenoic acid. Pharmacol Res 40: 211- 25.

13. Simopoulos A.P. 1991. Omega-3 fatty acids in health and disease, and in growth and development. Am J Clin Nutr 54:438-463.

14. Simopoulos, A.P. 1999. Essential fatty acids in health and chronic disease. Am J Clin Nutr, 70(3):560S-569S.

15. Anderson GJ, Connor We, Corliss JD. Docosahexaenoic acid is the preferred dietary n-3 faty acid for the development of the brain and retina. Pediatr Res 27:89-97, 1990.

16. Hornstra, G. 2000. Essential fatty acids in mothers and their neonates. Am J Clin Nutr 71 (Suppl.1): 1262s-1269s.

17. Uauy R and Valenzuela A. 2000. Marine oils: the health benefits of n-3 fatty acids. Nutrition 16: 680-684.

18. Connor W.E. 2000. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71(Suppl. 1): 171s-175.s.

19. Oh R. Practical applications of fish oil (ω-3 fatty acids) in primary care. J Am Board Family Pract 18:28-36; 2005.

20. Freemantle E, Vandal M, Tremblay-Mercier J, Tremblay S, Blachère JC, Bégin ME, Brenna JT, Windust A and Cunnane SC. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostagl Leukotr Essent Fatty Acids 75:213-220, 2006.

21. Angerer P, von Schacky C. 2000. N-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol. 11: 57-63.

22. Barcelli, U, Glas-Greenwalt P and Pollack V. 1985. Enhancing effect of dietary supplement with n-3 f
atty acids on plasma fibrinolysis in normal subjects. Thromb Res 39 :307-12.

23. Beil FU, Terres W, Orgass M and Greten H. 1991. Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia. Atherosclerosis 90 :95-97.

24. Bonaa KH, Bjerve KS, Staume B, Gram IT and Thelle D. 1990. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso Study. N Engl J Med 322 :795-801.

25. Harris, W.S. 1989. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J. Lipid Res. 30: 785-807.

26. Harris, W.S. and O’Keefe, J.H. 2001. Cardioprotective effets of omega-3 fatty acids. Nutr Clin Pract 16: 6-12.

27. Hooper L et al. 2006).Risks and benefits of omega-3 fats for mortality, cardio24vascular disease, and cancer: systematic review. Brit Med J 332: 752-760.

28. Kang JX and Leaf A. 1996. The cardiac antiarrhythmic effects of polyunsaturated fatty acid. Lipids 31: S41-44.

29. Knapp, H.R., and FitzGerald, G.A. 1989. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N. Engl. J. Med. 320:1037-43.

30. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747-2757; 2002.

31. Leaf A, Kang JX, Xiao Y-F, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of
prevention of arrhythmias by n-3 fish oils. Circulation 107:2646-2652; 2003.

32. Lemaitre RN, et al. 2002. N-3 polyunsaturated fatty acids, fatal ischemic heart disease and non-fatal myocardial infarction in older adults. The Cardiovascular Health Study. Am J Clin Nutr 76:319-25.

33. Lorgeril M, et al. 1999. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779-85.

34. Rissanen T, et al. 2000. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events. The Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation;102:2677-9.

35. Wang C, Harris WS, Chung M, et al. 2006. n-3 fatty acids from fish or fish-oil supplements but not a-linoleic acid, benefit cardiovascular outcomes in primary and secondary prevention studies: a systematic review. Am J. Clin Nutr 84:5-17.

36. Cleland LG, French JK, Betts WH, Murphy GA and Elliot MJ 1988. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J. Rheumatol. 15:1471-75.

37. Fortin, P.R., Lew, R.A., Liang, M.H., et al. 1995. Validation of a meta-analysis: The effetsc of fish oil in rheumatoid arthritis. J Clin Epidemiol 48:1379-1390.

38. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis & Rheumatism 37:824-829; 1994.

39. Grimble RF. 1998. Nutritional modulation of cytokine biology. Nutrition 14: 634-40.

40. Harbige LS. 1998. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc Nutr Soc. 57: 555-62

41. Heller A, Koch T, Schmeck J, van Ackern K. 1998. Lipid mediators inflammatory disorders. Drugs 55: 487-96.

42. Skoldstam L, Borjesson O, Kjallman A, Seiving B, Akesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand J Rheum 21:178-185; 1992.

43. Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 27:2343-2346; 2000.

44. Freeman MP. 2000. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry. 12: 159-65.

45. Haag M. 2003. Essential fatty acids and the brain. Can J Psych 48:195-203.

46. Hibbeln Jr. 1998. Fish consumption and major depression. Lancet 351: 1213.

47. Peet, M., Glen I. and Horrobin D.F. Phospholipid Spectrum Disorder in Psychiatry. Marius Press, 1999.

48. Stoll AL, et al. 1999. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56(5): 407–412.

49. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled studies. J Am Coll Nutr 28:525-542, 2009.

50. Lespérance F, Frasure-Smith N, st-Andre E, Turecki G, Lespérance P, Wisniewski SR. THe efficacy of omega-3 supplementation for major depression : a randomized controlled trial. J Clin Psychiatry 2010 Jun 15.

51. Bégin ME. 1987 Effects of polyunsaturated fatty acids and of their oxidation products on cell survival. Chem Phys Lipids 45:269-313.

52. Bégin, ME, Ells G, Das UN and Horrobin DF. 1986 Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 77:1056-1062.

53. Bégin ME, Ells G and Horrobin DF. 1988. Polyunsaturated fatty acid-induced cytotoxicity

54. against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 80 :188-194.

55. Bégin ME, Sircar S and Weber JM. (1994) Greater sensitivity of Human MDR cancer cells to polyunsaturated fatty acids than their
non-MDR counterparts. J Natl Cancer Inst 86: 638-639.

56. Burns CP, Wagner BA. 1993. Effects of exogenous lipids on cancer and cancer chemotherapy. Drug Saf 8: 57-68.

57. Guffy M, North JA. Burns CP. 1984. Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L121-0 murine leukemia cells. Cancer Res 44:1863-6.

58. Jiang WG, Bryce RP, Horrobin DF. 1998. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Critical Reviews in Oncol Hematol 27: 179-209.

59. Johanning GL. 1996. Modulation of breast cancer cell adhesion by unsaturated fatty acids. Nutrition 12:810-6.

60. Kinsella JE, Black JM. 1993. Effects of polyunsaturated fatty acids on the efficacy of antineoplastic agents toward 15178y lymphoma cells. Biochem Pharmacol 45:1881-7.

61. Plumb JA, Luo W. Kerr DJ. 1993. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin. Br J Cancer 67:728-33.

62. Rose DP, Connolly JM, Coleman M. 1996. Effect of w-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res 2: 1751-6.

63. Rose DP, Connoly JM, Meschter CL. 1991. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83:1491-5.

64. Santé Canada. Monographie des suppléments de multivitamines/minéraux. 2007.

65. Preedy VR, Burrow GN and Watson R (eds). Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects, Amsterdam, Academic Press, 2009.

66. Braverman LE and Utiger RD (Eds). Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text. Lippincott, Williams and Wilkins, 2005.

67. Venturi S and Bégin ME. Thyroid hormone, iodine and human brain evolution. In: Cunnane SC. and Stewart KM. Human Brain Evolution, The Influence of Freshwater and Marine Food Resources. Wiley-Blackwell, NJ, 2010.

68. Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev 75:319-631, 2000.

69. Bégin ME, Langlois MF, Lorrain D and Cunnane SC. Thyroid function and cognition during aging. Curr Gerontol Geriat Res doi:10.1155/2008/474868.

70. Bauer M, London ED, Silverman DHS, Rasgon N, Krichleiner J and Whybrow PC. Thyroid, brain and mood modulation in affective disorders: insights from molecular research and function brain imaging. Pharmacopsychiatry 36:S215-S221, 2003.

71. Abraham GE. The History of Iodine in Medicine Part I: From Discovery to Essentiality.The Original Internist 13:29-36, 2006 .

72. Abraham GE, The History of Iodine in Medicine Part II: The Search for and the Discovery of Thyroid Hormones. The Original Internist 13: 67-70, 2006.

73. Bauer M, Goetez t, Glenn T and Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 20:1101-1114, 2008.

74. Bauer M, Heinz A and Whybrow PC. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 7:140-156, 2002.

75. Joffre RT and Sokolov ST. Thyroid hormone treatment of primary unipolar depression: a review. Int J Neurophsychopharmacol 3:143-147, 2000.

76. Joffe Rt, Sokolov ST and Levitt AJ. Lithium and triiodothyronine augmentation of antidepressants. Can J Psychiatry 51:791-793, 2006.

77. Stone OJ. The role of the primitive sea in the natural selection of iodides as a regulating factor in inflammation. Medical Hypotheses 25: 125-129,1988.

78. Küpper FC, Carpenter LJ, McFiggans GB et al. Iodide accumulation provides kelp with an inorganic antioxidant impacting atmospheric chemistry. Proc Nat Acad Sci USA 13: 6954-6958, 2008.

79. Venturi S and Venturi M. Iodide, thyroid and stomach carcinogenesis: Evolutionary story of a primitive antioxidant? Eur J Endocrinol 140: 371-372, 1999.

80. Venturi S and Venturi M. Evolution of dietary antioxidant defenses. European Epi-Marker, 1:1-12. 2007.

81. Katamine S, Hoshino N, Totsuka K and Suzuk, M. Effects of the long-term feeding of high-iodine eggs on lipid metabolism and thyroid function in rats. J Nutr Sci Vitaminol 31: 339-345, 1985.

82. Liu Y. Study on antioxidative unbalance and structural damage in iodine deficient rats. 12th International Thyroid Congress, Kyoto, 22-27 October, p. 559, 2000.

83. Liu Y. The damage role of free radical in iodine deficient children.12th International Thyroid Congress, Kyoto, 22-27 October, p.560, 2000.

84. Berking S, Czech N, Gerharz M. et al. A newly discovered oxidant defence system and its involvement in the development of Aurelia aurita (Scyphozoa Cnidaria): reactive oxygen species and elemental iodine control medusa formation. Int J Develop Biol 49: 969-976, 2005.

85. Cash WD, Gardy M, Carlson HE and Ekong EA. (1966) Mitochondrial swelling and lipid peroxidation studies with mixture of thyroxine and micromolar concentration of certain metal ions. J Biol Chem 241:1745-1750, 1966.

86. Oziol L, Faure P, Vergely C et al. In vitro free radical scavenging capacity of thyroid hormones and structural analogues. J Endocrinol
170:197-206, 2001.

87. Tseng YL and Latham KR. Iodothyronines: oxidative deiodination by hemoglobin and inhibition of lipid peroxidation. Lipids 19:96-102, 1984.

88. Ware CM and Wishner LA. The lipid antioxidant properties of iodine compounds. Lipids 3:182-183,1968.

89. Winkler R, Griebenow S and Wonisch W. Effect of iodide on total antioxidant status of human serum. Cell Biochem Function 18:143-146,2000.

90. Abnet CC, Fan JH, Kamangar F et al. Self-reported goiter is associated with a significantly increased risk of gastric non cardia adenocarcinoma in a large population-based Chinese cohort. International J Cancer 119:1508-1510,2006.

91. Aceves C, Anguiano B and Delgado, G. Is Iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol and Neoplasia 10: 189-196, 2005.

92. Buchberger W, Winkler R, Moser M and Rieger G. Influence of iodide on cataractogenesis in emory mice. Ophthalmic Res 23 : 303-308,1991.

93. Cann SA, Van Netten JP and Van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control 11: 121-127,2000.

94. Eskin BA. Iodine and mammary cancer. Adv Exp Med Biol 91: 293-304, 1977.

95. Elstner E., Adamczyk R, Krome R and Furch A. The uptake of potassium iodide and its effects as an antioxidant in isolated rabbit eyes. Ophthalmologica 191: 122–126, 1985.

96. Funahashi H, Imai T and Tanaka Y. Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. J Surg Oncol 61: 209-213, 1996.

97. Kessler JH. The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia. Breast J 10: 328-336, 2004.

98. Muranov K, Poliansky N, Winkler R. et al. Protection by iodide of lens from selenite-induced cataract. Graefe’s Arch Clin Experim Ophthalmol 242: 146-151, 2004.

99. Gołkowski F, Szybiński Z, Rachtan J et al. Iodine prophylaxis-the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr 46: 251-256, 2007.

100. Rieger G, Winkler R, Buchberger W and Moser M. Iodine distribution in a porcine eye model following iontophoresis. Ophthalmologica 209 : 84-87, 1995.

101. Venturi S.Is there a role for iodine in breast diseases? The Breast, 10: 379-382, 2001.

102. Venturi S, Donati FM, Venturi A et al. Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Pathol 4 :11-17, 2000.

103. Venturi S, Marani L and Magni MA. Syndrome thyro-gastric: Study on the relation between alimentary iodine deficiency and gastric cancer. In: Epidemiology, Prevention and Early Detection of Gastric Cancer (eds G Ghironzi, CE Jackson, and BM Schuman), CIC Edit., Rome, pp. 272-281, 1987.

104. Smyth PP. The thyroid, iodine and breast cancer. Breast Cancer Re, 5: 235-238, 2003.

105. Smyth PP. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 19:121-130, 2003.

106. Bianco AC and Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Investigation 116: 2571-2579, 2006.

107. Cunnane, S. Survival of the Fattest: The Key to Human Brain Evolution. World Scientific Publishing Company, Singapore, p.115-160, 2005.

108. Cunnane, SC. Human brain evolution: a question of solving key nutritional and metabolic constraints on mammalian brain development. In: Cunnane, SC. and Stewart, KM. (Eds) Human Brain Evolution, The Influence of Freshwater and Marine Food Resources, Wiley-Blackwell , NJ, pp. 33-64, 2010.

109. http://oceanworld.tamu.edu/resources/oceanography-book/marinefoodwebs.htm

110. http://drake.marin.k12.ca.us/stuwork/rockwater/PLANKTON/Food%20Chain.htm

111. Bégin ME, Plourde M, Pifferi F and Cunnane SC. Are fish and docosahexaenoic acid linked to lower risk of cognitife decline and Alzheimer’s disease? In: Recent Advances on Nutrition and the Prevention of Alzheimer’s Disease, Ramassamy C and Bastianetto S, eds, Transworld Reasearch Network, Kerala, India p. 71-95, 2010.

112. Féart C, Samieri C and Barberger-Gateau P. Diet and Alzheimer’s disease: New evidence from epidemiological studies. In: Recent Advances on Nutrition and the Prevention of Alzheimer’s Disease, Ramassamy C and Bastianetto S, eds, Transworld Reasearch Network, Kerala, India p. 19-40, 2010.

113. Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 48:329-256, 2009.

114. Gillette-Guyonnet S, Abellan Van Kan G, Andrieu S, et al. IANA task force on nutrition and cognitive decline with aging. J Nutr Health & Aging 11:132-152, 2007.

115. Cocchi M and Venturi S. Iodide, antioxidant function and omega-6 and omega-3 acids: a new hypothesis of a biochemical cooperation? Prog Nutr 2:15-19, 2000.

116. Hooijmans CR and Kiliaan AJ. Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 585:176-196, 2008.

117. Salem N, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36 :945-959, 2001.

118. Bazan NG. Cell survival matters: docosahexaenoic acid signaling,neuroprotection and photoreceptors. Trends Neurosci 29 :263-271, 2006.

119. Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opinion Clin Nutri Metabolic Care 10:136–41, 2007.

120. Fotuhi M, Mohassel P and Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nature Clin Practice Neurol 5:140-152, 2009.

121. Maclean DH, Issa AM, Newberry Sj, Mojica WA, Morton Sc, et al. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Evid Rep Technol Assess (Summ):1-3, 2005.

122. Ramassamy C, Doggui S, Arsenault M and Dao L. Towards a nutritional approach for the prevention of Alzheimer’s disease: Promise of polyphenolic components. In: Recent Advances on Nutrition and the Prevention of Alzheimer’s Disease, Ramassamy C and Bastianetto S, eds, Transworld Reasearch Network, Kerala, India p. 1- 18, 2010.